Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Safrit

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
The Journal of Experimental Medicine|February 1, 1994
Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitopeJ T Safrit, C A Andrews, T Zhu, et al.
AIDS Research and Human Retroviruses|March 1, 1994
Quantitative assessment of human immunodeficiency virus type 1 replication in human xenografts of acutely infected Hu-PBL-SCID miceR A Koup, R M Hesselton, J T Safrit, et al.
Science (New York, N.Y.)|November 8, 1996
Response: HIV-1 Evolution and Disease ProgressionS M Wolinsky, K J Kunstman, J T Safrit, et al.
Journal of Virology|July 1, 1994
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndromeR A Koup, J T Safrit, Y Cao, et al.
AIDS (London, England)|January 1, 1997
CD8+ T-cell-mediated suppression of HIV replication in the first year of life: association with lower viral load and favorable early survivalH Pollack, M X Zhan, J T Safrit, et al.
AIDS (London, England)|January 1, 1993
hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120J T Safrit, M S Fung, C A Andrews, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Processing of HIV-1 envelope glycoprotein for class I-restricted recognition: dependence on TAP1/2 and mechanisms for cytosolic localizationR L Ferris, C Hall, N V Sipsas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1995
An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTLS A Hammond, R P Johnson, S A Kalams, et al.
Journal of Virology|March 30, 2005
Induction of humoral immune responses following vaccination with envelope-containing, formaldehyde-treated, thermally inactivated human immunodeficiency virus type 1B Poon, J T Safrit, H McClure, et al.
Journal of Virology|June 8, 2001
Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaquesD C Montefiori, J T Safrit, S L Lydy, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Experimental Medicine|February 1, 1994
Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitopeJ T Safrit, C A Andrews, T Zhu, et al.
AIDS Research and Human Retroviruses|March 1, 1994
Quantitative assessment of human immunodeficiency virus type 1 replication in human xenografts of acutely infected Hu-PBL-SCID miceR A Koup, R M Hesselton, J T Safrit, et al.
Science (New York, N.Y.)|November 8, 1996
Response: HIV-1 Evolution and Disease ProgressionS M Wolinsky, K J Kunstman, J T Safrit, et al.
Journal of Virology|July 1, 1994
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndromeR A Koup, J T Safrit, Y Cao, et al.
AIDS (London, England)|January 1, 1997
CD8+ T-cell-mediated suppression of HIV replication in the first year of life: association with lower viral load and favorable early survivalH Pollack, M X Zhan, J T Safrit, et al.
AIDS (London, England)|January 1, 1993
hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120J T Safrit, M S Fung, C A Andrews, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Processing of HIV-1 envelope glycoprotein for class I-restricted recognition: dependence on TAP1/2 and mechanisms for cytosolic localizationR L Ferris, C Hall, N V Sipsas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1995
An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTLS A Hammond, R P Johnson, S A Kalams, et al.
Journal of Virology|March 30, 2005
Induction of humoral immune responses following vaccination with envelope-containing, formaldehyde-treated, thermally inactivated human immunodeficiency virus type 1B Poon, J T Safrit, H McClure, et al.
Journal of Virology|June 8, 2001
Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaquesD C Montefiori, J T Safrit, S L Lydy, et al.
Pageof 3